Maximo Maislos

2.5k citations
37 papers · 1.9k · 1 hit paper · h-index 16

Impact in

Papers in

Maximo Maislos

37 papers receiving 1.8k citations

Maximo Maislos's Hit Papers

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial 2017 · 653 citations
6530+3+6Years since publication200400600

Peers

Maximo Maislos
Comparison fields: 5 of 109
  • Endocrinology, Diabetes and Metabolism 641
  • Physiology 635
  • Pharmacy 111
  • Pharmacology 336
  • Endocrine and Autonomic Systems 58
Replace Karl Z. Nadolsky with:
Karl Z. Nadolsky United States
Nicholas R. Fuller Australia
Thomas Pozefsky United States
Diego Bellido Spain
Marie‐Christine Pouliot Canada
Sophia Zollner-Kiechl Austria
Samir Arora United States
Carl N. Peters United Kingdom
N. Melchionda Italy
Alison C. Barnes United Kingdom
Maximo Maislos relative to Karl Z. Nadolsky United States Karl Z. Nadolsky's profile →
Citations per field
00.5×2×4×6×7.1×
Karl Z. Nadolsky · 1×
Citations per year

Countries citing papers authored by Maximo Maislos

Since Specialization
Citations

This map shows the geographic impact of Maximo Maislos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximo Maislos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximo Maislos more than expected).

Fields of papers citing papers by Maximo Maislos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximo Maislos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximo Maislos. The network helps show where Maximo Maislos may publish in the future.

Co-authors

The 25 scholars most cited alongside Maximo Maislos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maximo Maislos Line = papers co-authored together Maximo Maislos links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Hit paper breakdown →
2017653
2 2008323
3 2012204
4 1993118
5 199878
6 199970
7 200451
8 198146
9 200139
10 201135
11
Computerized community cholesterol control (4C): meeting the challenge of secondary prevention.
200931
12 199730
13 201630
14 199227
15 198623
16 200520
17 200115
18 199913
19 198812
20
Leiomyoblastoma associated with intractable hypercalcemia and elevated 1,25-dihydroxycholecalciferol levels. Treatment by hepatic enzyme induction.
198511

About Maximo Maislos

Maximo Maislos is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Pharmacy, Genetics and Surgery, having authored 37 papers that have together received 1.9k indexed citations. Recurring topics across this work include Diet and metabolism studies (6 papers), Diabetes and associated disorders (5 papers), Diabetes Management and Research (4 papers), Diabetes Management and Education (3 papers), Dietary Effects on Health (3 papers), Pharmacology and Obesity Treatment (3 papers), Obesity and Health Practices (3 papers) and Diabetes Treatment and Management (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (641 citations), Physiology (635 citations), Pharmacy (111 citations), Pharmacology (336 citations) and Endocrine and Autonomic Systems (58 citations). Maximo Maislos has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Barbara Zahorska‐Markiewicz, Nick Finer, Yves Schütz, Dragan Micić, Hermann Toplak, Vojtěch Hainer, Gabriela Diana Roman, Constantine Tsigos, Elisabeth M. H. Mathus-Vliegen and Arnaud Basdevant. Their work appears in journals such as Diabetes Care, Obesity Facts, Acta Diabetologica, Diabetes Obesity and Metabolism and Diabetologia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact